Latest Investor Relations News

HitIQ Limited attributes recent share price and volume spikes to a recent $1.4 million private placement and investor buying, denying any undisclosed material information.

EcoGraf has appointed Sven Olsson as an independent director and Peter Schuhmacher as a board advisor to bolster its European investor relations and advance its HFfree purification technology amid growing ESG demand.

Identitii has secured a $20 million convertible note facility with The Blackstone Mercantile Group, including a $5 million binding commitment subject to shareholder approval. The funding aims to support growth of the BNDRY platform and strengthen the company’s balance sheet ahead of a planned cashflow breakeven.

PEXA faces a proposed 20% cut in regulated ELNO service fees, risking a $70 million revenue reduction over a year. The company urges a phased approach to mitigate business impact as IPART opens public consultation.

James Hardie Industries releases its 2026 AGM materials, highlighting a $4.8 billion sales year boosted by AZEK acquisition, board renewals, and a revamped executive pay structure.

BlackRock Investment Management (Australia) has announced the final cash distribution amounts for a broad suite of iShares ETFs, with payments scheduled for 13 July 2026.

Bravura Solutions plans to list on the London Stock Exchange's AIM market by late July 2026, aiming to tap into UK and European institutional investors while maintaining its ASX primary listing.

Matsa Resources has restructured its board and management team, appointing three new non-executive directors with deep technical and commercial expertise to support the expansion and development of its Lake Carey gold asset.

Truscreen Group has issued nearly 150 million new shares at NZ$0.013 each, expanding its share base by 17.4% following a renounceable rights issue. The fully paid shares rank equally with existing stock, lifting total ordinary shares to just over one billion.

Recce Pharmaceuticals secured A$4 million through an institutional placement and launched a Share Purchase Plan to raise up to an additional A$4 million, bolstering funds for commercial licensing and ongoing clinical programs.

Skin Elements Limited has secured a $900,000 placement at a 25% discount to recent prices, bolstering its balance sheet to advance its natural biotechnology product range. The company also appointed Rod Nicholas as non-executive chairman and engaged Phoenix Global Investments for investor relations.

Transurban Group (ASX: TCL) declared a 35-cent unfranked distribution per stapled security for the six months ending 30 June 2026, payable in August with no approvals required.